基于抗体的免疫疗法用于治疗血液恶性瘤
Justyna Jureczek1, Krzysztof Kałwak2, Piotr Dzięgiel1
1Division of Histology and Embryology, Department of Human Morphology and Embryology, Faculty of Medicine, Wroclaw Medical University, 50-368 Wroclaw, Poland.
Cancers
|January 8, 2025
概括
免疫疗法,特别是单克隆抗体 (mAbs),为治疗血液性恶性瘤 (HMs) 提供了一个有前途的第四支柱. 本综述详细介绍了基于抗体的治疗方法的进展,如抗体-药物合物和检查点抑制剂.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
背景情况:
- 血液性恶性瘤 (HM) 仍然具有挑战性,尽管有进展,但仍难以有效治疗.
- 传统疗法在有效性和安全性方面存在重大限制.
- 瘤免疫生物学的洞察力推动了新的免疫治疗策略.
研究的目的:
- 为医疗人员提供当前免疫治疗策略的全面概述.
- 突出单克隆抗体 (mAbs) 及其衍生物在HM治疗中的作用.
- 讨论抗体-药物合物,双特异性T细胞参与剂和检查点抑制剂.
主要方法:
- 对血液性恶性瘤的免疫疗法的当前文献的综述.
- 对已批准和正在研究的基于抗体的治疗方法的分析.
- 专注于单克隆抗体及其先进衍生物.
主要成果:
- 单克隆抗体 (mAbs) 及其衍生物在HMs中显示出显著的临床结果.
- 基于抗体的疗法是癌症免疫疗法的成功策略.
- 各种基于抗体的免疫疗法已被批准或在临床试验中用于HMs.
结论:
- 免疫疗法,特别是基于抗体的方法,是HM治疗的关键支柱.
- 单克隆抗体及其结合物提供更高的疗效和向治疗.
- 未来的战略重点是T细胞激活和克服HM的免疫抑制.
相关概念视频
01:27Tumor Immunotherapy
472
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
472
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:36Humoral Immune Responses
71.3K
Overview
71.3K
01:31Hybridoma Technology
14.1K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.1K
01:22Bone Marrow Sampling and Transplants
279
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
279
01:21Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K